Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Phase II Trial GA101 Inbrutinib B CLL
ClinicalTrials.gov study NCT02666898. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-ce
ClinicalTrials.gov study NCT02935257. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy
ClinicalTrials.gov study NCT01556776. IPD Sharing: NO. Countries: 1. Publications: 2.
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
ClinicalTrials.gov study NCT04608318. IPD Sharing: NO. Countries: 13. Publications: 1.
Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
ClinicalTrials.gov study NCT00772811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
ClinicalTrials.gov study NCT01446133. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Intensified Rituimab Prephase Before FCR in Untreated B-CLL
ClinicalTrials.gov study NCT01370772. IPD Sharing: NO. Countries: 1. Publications: 3.
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01486797. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL
ClinicalTrials.gov study NCT01728207. IPD Sharing: Not stated. Countries: 1. Publications: 5.
AID overexpression leads to aggressive murine CLL and non-Ig mutations that mirror human neoplasms
Open the record for dataset details and reuse information.
The antigen causing IgG hexamerization in patients with Chronic lymphocytic leukemia (CLL) is Alpha 2 macroglobulin (A2M)
Open the record for dataset details and reuse information.
Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00899431. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01924169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT01243190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alemtuzumab + Rituximab Consolidation in CLL
ClinicalTrials.gov study NCT00771602. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients
ClinicalTrials.gov study NCT02481297. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04204057. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00751296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01373229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00718549. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.